Edwards Lifesciences (EW) Tops Q4 EPS by 3c, Offers Q1 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $99.37 +4.39%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.75, $0.03 better than the analyst estimate of $0.72. Revenue for the quarter came in at $767.7 million versus the consensus estimate of $759.54 million.
GUIDANCE:
Edwards Lifesciences sees Q1 2017 EPS of $0.79-$0.89, versus the consensus of $0.81. Edwards Lifesciences sees Q1 2017 revenue of $760-800 million, versus the consensus of $778.1 million.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- PureCycle Technologies, Inc. (PCT) Tops Q3 EPS by 25c
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
